Riccardo Lobefaro
0000-0003-3484-9718
9 papers found
Refreshing results…
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
Circulating biomarkers in malignant pleural mesothelioma
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: the role of clinical-pathological variables and inflammatory biomarkers
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
Missing publications? Search for publications with a matching author name.